MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI : revenue, balance sheet and financial ratios

MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI is a French company founded 10 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in VILLERS-LES-NANCY (54600), this company of category PME shows in 2025 a revenue of 34 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI (SIREN 818404006)
Indicator 2025 2024 2023 2022 2021 2020 2018
Revenue 34 475 € 29 944 € 5 215 € N/C N/C N/C N/C
Net income -82 426 € 14 184 € -41 461 € -16 862 € 141 739 € -11 486 € -6 218 €
EBITDA 8 024 € 20 276 € -25 355 € -4 908 € -24 546 € -6 801 € -1 871 €
Net margin -239.1% 47.4% -795.0% N/C N/C N/C N/C

Revenue and income statement

In 2025, MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI achieves revenue of 34 k€. Over the period 2023-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +157.1%. Vs 2024, growth of +15% (30 k€ -> 34 k€). After deducting consumption (0 €), gross margin stands at 34 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 8 k€, representing 23.3% of revenue. Warning negative scissor effect: despite revenue change (+15%), EBITDA varies by -60%, reducing margin by 44.4 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Net income is negative at -82 k€ (-239.1% of revenue), which will impact equity.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

34 475 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

34 475 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

8 024 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-17 117 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-82 426 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

23.3%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 15%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 86%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

15.43%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

86.187%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-179.275%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-1.877

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

91.1%

Solvency indicators evolution
MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI

Sector positioning

Debt ratio
15.43 2025
2023
2024
2025
Q1: 0.14
Med: 27.24
Q3: 146.28
Good +13 pts over 3 years

In 2025, the debt ratio of MARTINVEST SOCIETE DE PAR... (15.43) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
86.19% 2025
2023
2024
2025
Q1: 17.38%
Med: 54.75%
Q3: 87.41%
Good

In 2025, the financial autonomy of MARTINVEST SOCIETE DE PAR... (86.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-1.88 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.77 years
Q3: 6.12 years
Excellent

In 2025, the repayment capacity of MARTINVEST SOCIETE DE PAR... (-1.88) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 5048.54. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 88.4x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

5048.539

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

88.397

Liquidity indicators evolution
MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI

Sector positioning

Liquidity ratio
5048.54 2025
2023
2024
2025
Q1: 159.67
Med: 1116.63
Q3: 6512.12
Good -7 pts over 3 years

In 2025, the liquidity ratio of MARTINVEST SOCIETE DE PAR... (5048.54) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
88.4x 2025
2023
2024
2025
Q1: -191.54x
Med: -25.42x
Q3: 0.0x
Excellent +37 pts over 3 years

In 2025, the interest coverage of MARTINVEST SOCIETE DE PAR... (88.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 84 days. Excellent situation: suppliers finance 84 days of the operating cycle (retail model). Overall, WCR represents 2 days of revenue, i.e. 227 € to permanently finance.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

227 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

84 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

2 j

WCR and payment terms evolution
MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI

Positioning of MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Based on 170 transactions of similar company sales (all years), the value of MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI is estimated at 43 317 € (range 26 818€ - 70 899€). With an EBITDA of 8 024€, the sector multiple of 6.8x is applied. The price/revenue ratio is 0.71x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
170 transactions
26k€ 43k€ 70k€
43 317 € Range: 26 818€ - 70 899€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
8 024 € × 6.8x
Estimation 54 641 €
33 106€ - 96 298€
Revenue Multiple 30%
34 475 € × 0.71x
Estimation 24 446 €
16 339€ - 28 568€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 170 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI

What is the revenue of MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI ?

The revenue of MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI in 2025 is 34 k€.

Is MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI profitable?

MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI recorded a net loss in 2025.

Where is the headquarters of MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI ?

The headquarters of MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI is located in VILLERS-LES-NANCY (54600), in the department Meurthe-et-Moselle.

Where to find the tax return of MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI ?

The tax return of MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI operate?

MARTINVEST SOCIETE DE PARTICIPATIONS FINANCIERES DE PROFESSION LIBERALE A RESPONSABILITE LIMITEE DE PHARMACIENS D'OFFICI operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.